Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts

Plain-language summary

This study examined the expression levels of the SOCS3, IFN-α, and IFN-β genes in people with cutaneous warts. It enrolled patients aged 18-50 with various types of skin warts. It is a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Sohag University

Intervention

Detection of expression of SOCS3 gene, Detection of expression of IFN-α gene, Detection of expression of IFN-β gene

Start date

4/15/2023

Estimated completion

12/30/2023

Countries

Egypt

Related genes

Locations

• Sohag, Egypt

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* The study will include patients with cutaneous warts of various types aged 18-50 years old.

Exclusion Criteria:

* 1\. Pregnancy 2. Lactation 3. Patient on anti-inflammatory and antioxidant drugs 4. Skin infections, other than warts 5. Skin diseases 6. Systemic infection. 7. Malignancies